Craig Gravina, chief technology officer, ObvioHealth, sheds some light on the current digital therapeutics landscape, including regulatory challenges, the prescription DTx model, and solutions to improve clinical trial research.
Craig Gravina, chief technology officer, ObvioHealth, sheds some light on the current digital therapeutics landscape, including regulatory challenges, the prescription DTx model, and solutions to improve clinical trial research.
Craig Gravina, chief technology...